Clin2
NCT06995053Possibly a fitActive, not recruiting

Prostate cancer radiation therapy with motion monitoring

Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8

Part of Cancer, Kidney & urinary clinical trials.

This trial tests a precise radiation technique for prostate cancer that tracks the prostate during treatment. It aims to deliver higher radiation doses more safely, which may improve outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
91 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with prostate cancer that has not spread beyond the pelvis area.
  • You are 18 years or older.
  • You have not had whole gland treatment for your prostate before (like cryosurgery, HIFU, or brachytherapy).
  • You have not had radiation therapy to your pelvis before.
  • You do not have a history of Crohn's disease, ulcerative colitis, or ataxia telangiectasia.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07276438Recruiting
Image-guided radiation therapy for localized prostate cancer

This trial tests a precise radiation technique that adapts to your body's daily changes. It may offer better outcomes for men with prostate cancer that hasn't spread outside the pelvic area.

Los Angeles, California
NCT07769372Not yet recruiting
MRI-guided radiation therapy for prostate cancer

This trial tests whether a special type of radiation therapy, guided by MRI, can treat prostate cancer with fewer side effects. The treatment is given in a highly precise way to target the cancer while sparing healthy tissue.

Irvine, California
NCT06067269Recruiting· Phase 2
Hormone therapy and precise radiation for intermediate-risk prostate cancer

This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.

Los Angeles, California
NCT06325046Recruiting
Adaptive radiation therapy for localized prostate cancer

This trial tests a type of radiation that adapts to your body's changes during treatment. It is for men with low- to intermediate-risk prostate cancer that hasn't spread.

Albert Lea, Minnesota
NCT05946213Recruiting· Phase 3
Shorter radiation treatment for high-risk prostate cancer

This trial tests whether a shorter course of radiation works as well as the usual longer course for people with high-risk prostate cancer. The goal is to keep cancer control while possibly reducing treatment time and inconvenience.

Birmingham, Alabama
NCT07293585Recruiting· Phase 3
Precision radiation to protect erectile function in prostate cancer

This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.

Los Angeles, California

Hear when a new Localized Prostate Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.